Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Baxter
Merck
Dow

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090600

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 090600 describes GLYCOLAX, which is a drug marketed by Lannett Co Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the GLYCOLAX profile page.

The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and twenty-one drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.
Summary for 090600
Tradename:GLYCOLAX
Applicant:Lannett Co Inc
Ingredient:polyethylene glycol 3350
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 090600
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLYCOLAX polyethylene glycol 3350 FOR SOLUTION;ORAL 090600 ANDA Lannett Company, Inc.. 62175-190 62175-190-07 119 g in 1 BOTTLE (62175-190-07)
GLYCOLAX polyethylene glycol 3350 FOR SOLUTION;ORAL 090600 ANDA Lannett Company, Inc.. 62175-190 62175-190-14 238 g in 1 BOTTLE (62175-190-14)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;ORALStrength17GM/PACKET
Approval Date:Oct 6, 2009TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;ORALStrength17GM/SCOOPFUL
Approval Date:Oct 6, 2009TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Mallinckrodt
Harvard Business School
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews